Skip to main content
. 2021 Mar 19;16(3):e0246314. doi: 10.1371/journal.pone.0246314

Table 3. Relationship between hospitalization time and study variables.

Mean ± SD Median Q1 Q3 P-value
Gender
    Male 10 ± 5 7 6 14 0.045
    Female 7 ± 5 7 1 10
Age (Years)
    < 45 6 ± 5 7 1 10 0.007
    45–64 7 ± 4 7 6 10
    ≥ 64 10 ± 5 9 6 14
BMI
    Normal 11 ± 5 13 7 14 0.244
    Overweight 9 ± 6 8 5 13
    Obese 8 ± 6 6 1 11
Medication
    IFB (Betamethasone) 8 ± 8 5 1 16 0.025
    Kaletra or Lopinavir/ritonavir (LPV/r) 7 ± 1 7 7 8
    IVIg (Intravenous immunoglobulin) 9 ± 5 11 7 14
Oxygen saturation (%)
    < 90 9 ± 5 8 6 12 <0.001
    90–93 10 ± 4 9 7 14
    > 93 4 ± 6 1 1 3
Underlying disease
    Non 8 ± 5 7 5 13 0.536
    Internal diseases 9 ± 6 8 6 14
    Coronary heart disease 8 ± 5 9 1 12
    Neurological disorders 5 ± 2 5 3 7
Blood Type
    A (positive or negative) 9 ± 5 7 6 13 <0.001
    B (positive or negative) 3 ± 2 3 1 6
    AB (positive or negative) 10 ± 5 9 7 14
    O (positive or negative) 5 ± 4 5 5 8
Rhesus (Rh) factor
    Yes 7 ± 4 7 5 10 0.028
    No 10 ± 6 9 6 14
Having a job
    Yes 10 ± 5 11 6 14 0.220
    No 9 ± 5 8 5 12
Smoking
    Yes 12 ± 6 12 7 14 0.058
    No 8 ± 5 7 5 12
Drug usage
    Yes 12 ±6 12 7 14 0.099
    No 8 ± 5 8 3 12
Staff member of Hospital
    Yes - - - - -
    No 9 ± 6 8 5 13
Travel history in the last 14 days
    Yes 6 ± 0 6 6 6 0.439
    No 9 ± 6 8 5 14
Having contact with a person who has been diagnosed with COVID-19
    Yes 10 ± 7 10 2 15 0.545
    No 9 ± 4 8 6 11
Having contact with a person who has been suspected with COVID-19
    Yes 8 ± 4 7 6 13 0.891
    No 9 ± 6 8 5 12
Having contact with animals
    Yes 10 ± 10 7 1 12 0.946
    No 8 ± 5 8 5 13
Consuming Hydroxychloroquine
    Yes 8 ± 6 7 6 8 0.252
    No 8 ± 6 7 3 12
Consuming Azithromycin
    Yes 9 ± 5 9 5 14 0.239
    No 8 ± 6 7 6 8

The variables were expressed as mean ± Standard Deviation, Median, Q1, and Q3, where the interquartile range (IQR) is equal to Q1—Q3.

BMI stands for Body Mass Index.